Alcanza Clinical Research Expands Reach and CNS Capabilities with Acquisition of Vertex Research

Apr 12, 2023 | Blog

BOSTON, MA, April 11, 2023   ̶   Alcanza Clinical Research, a mission-focused investigator site network, announces the acquisition of Vertex Research Group, an investigator site based in Clermont, Florida, that specializes in psychiatry and neurology indications.

“The drug development pipeline for CNS indications is thriving,” said Carlos Orantes, CEO of Alcanza.  “The addition of Vertex strengthens our capabilities to better address huge and growing unmet medical needs in dementia, depression, anxiety, and related areas, especially in older populations. Their location in greater Orlando provides access to a diverse range of patients in one of the fastest growing cities in Florida.”

“We are delighted to join the Alcanza network,” said Dr. Ayesha Lall, Co-Founder, and Principal Investigator at Vertex Research Group. “We are entering an era of research where sponsors must make fundamental changes to their patient outreach and trial inclusion strategies. Alcanza’s commitment to diverse and inclusive research emphasis is a critical step to creating better medicines and sustainable health equity. Together with our combined capabilities, we will deliver rapid enrollment and exceptional patient experiences in advancing the next generation of equitable medicine.”

Vertex Research Group will retain its name. Dr. Lall will continue in the role of medical director and remain as a principal investigator of the site.

About Alcanza Clinical Research

Alcanza Clinical Research is an integrated network of dedicated research facilities focused on bringing clinical trial opportunities involving life-changing treatments and vaccines to all patients, especially those from under-represented communities.  With locations in Massachusetts, Michigan, New Hampshire, South Carolina, Virginia, and Florida, we specialize in a range of conditions across psychiatry, neurology, dermatology, and infectious disease therapeutic areas.

The Alcanza network includes six multi-specialty organizations in nine locations.

ActivMed Practices and Research conducts Phase I-IV research across multiple locations in Massachusetts and New Hampshire.

Boston Clinical Trials serves the Boston metro area with Phase II-IV studies.

Charlottesville Medical Research serves central Virginia patients with Phase II-IV studies.

Coastal Carolina Research Center offers Phase I-IV studies from the largest multi-therapeutic research site in the southeast United States.

Quest Research Institute provides Phase I-IV studies to southeastern Michigan patients and healthy volunteers.

Vertex Clinical Research specializes in Phase II-IV studies involving CNS indications.

Alcanza Public Relations